ALPS Advisors’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-138,825
| Closed | -$990K | – | 845 |
|
|
2020
Q1 | $990K | Sell |
138,825
-14,888
| -10% | -$106K | 0.02% | 275 |
|
|
2019
Q4 | $3.67M | Buy |
+153,713
| New | +$3.67M | 0.03% | 182 |
|
|
2018
Q2 | – | Sell |
-87,516
| Closed | -$2.86M | – | 982 |
|
|
2018
Q1 | $2.86M | Buy |
87,516
+15,210
| +21% | +$497K | 0.02% | 186 |
|
|
2017
Q4 | $3.52M | Buy |
72,306
+15,518
| +27% | +$755K | 0.02% | 156 |
|
|
2017
Q3 | $3.07M | Buy |
56,788
+5,320
| +10% | +$287K | 0.02% | 165 |
|
|
2017
Q2 | $2.89M | Buy |
51,468
+2,823
| +6% | +$159K | 0.02% | 163 |
|
|
2017
Q1 | $1.91M | Sell |
48,645
-5,691
| -10% | -$223K | 0.01% | 180 |
|
|
2016
Q4 | $1.22M | Sell |
54,336
-17,693
| -25% | -$397K | 0.01% | 203 |
|
|
2016
Q3 | $1.64M | Sell |
72,029
-7,299
| -9% | -$166K | 0.01% | 196 |
|
|
2016
Q2 | $1.87M | Buy |
79,328
+16,013
| +25% | +$378K | 0.02% | 173 |
|
|
2016
Q1 | $1.29M | Sell |
63,315
-10,233
| -14% | -$209K | 0.01% | 175 |
|
|
2015
Q4 | $3.78M | Sell |
73,548
-8,727
| -11% | -$449K | 0.04% | 134 |
|
|
2015
Q3 | $35.1K | Buy |
82,275
+30,616
| +59% | +$13K | 0.04% | 133 |
|
|
2015
Q2 | $2.35M | Buy |
51,659
+27,464
| +114% | +$1.25M | 0.02% | 156 |
|
|
2015
Q1 | $918K | Buy |
+24,195
| New | +$918K | 0.01% | 187 |
|